Please use this identifier to cite or link to this item:
|Title:||Sos1 Regulates Macrophage Podosome Assembly and Macrophage Invasive Capacity||Authors:||Baruzzi, Anna
|Keywords Plus:||VIRUS-TRANSFORMED FIBROBLASTS;TYROSINE KINASE ABL;3-DIMENSIONAL MIGRATION;PLASMA-MEMBRANE;KEY REGULATORS;INVADOPODIA;SRC;PHOSPHORYLATION;PROTEIN;HCK||Mesh headings:||Cell Movement;Macrophages;Neoplasms;Proto-Oncogene Proteins;SOS1 Protein;src-Family Kinases||Secondary Mesh headings:||Animals;COS Cells;Chlorocebus aethiops;Humans;Imatinib Mesylate;Mice;Neoplasm Invasiveness;Phosphorylation;Podosomes;Proto-Oncogene Proteins c-abl;rac GTP-Binding Proteins||Issue Date:||15-Nov-2015||Publisher:||AMER ASSOC IMMUNOLOGISTS||Journal:||Journal of immunology (Baltimore, Md. : 1950)||Abstract:||
Podosomes are protrusive structures implicated in macrophage extracellular matrix degradation and three-dimensional migration through cell barriers and the interstitium. Podosome formation and assembly are regulated by cytoskeleton remodeling requiring cytoplasmic tyrosine kinases of the Src and the Abl families. Considering that Abl has been reported to phosphorylate the guanine nucleotide exchange factor Sos1, eliciting its Rac-guanine nucleotide exchange factor activity, and Rac regulates podosome formation in myeloid cells and invadopodia formation in cancer cells, we addressed whether Sos1 is implicated in podosome formation and function in macrophages. We found that ectopically expressed Abl or the Src kinase Fgr phosphorylate Sos1, and the Src kinases Hck and Fgr are required for Abl and Sos1 phosphorylation and Abl/Sos1 interaction in macrophages. Sos1 localizes to podosomes in both murine and human macrophages, and its silencing by small interfering RNA results in disassembly of murine macrophage podosomes and a marked reduction of GTP loading on Rac. Matrix degradative capacity, three-dimensional migration through Matrigel, and transmigration through an endothelial cell monolayer of Sos1-silenced macrophages were inhibited. In addition, Sos1- or Abl-silenced macrophages, or macrophages treated with the selective Abl inhibitor imatinib mesylate had a reduced capability to migrate into breast tumor spheroids, the majority of cells remaining at the margin and the outer layers of the spheroid itself. Because of the established role of Src and Abl kinases to regulate also invadopodia formation in cancer cells, our findings suggest that targeting the Src/Abl/Sos1/Rac pathway may represent a double-edged sword to control both cancer-invasive capacities and cancer-related inflammation.
|Appears in Collections:||Articles|
Show full item record
checked on May 3, 2021
checked on Aug 31, 2020
WEB OF SCIENCETM
checked on Nov 24, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.